AllJournalThesisConferenceNewspaperPatentStandardYear BookBook|ResearcherProject
all languages  Chinese Only  Other Languages
Author:... Baik Yeonsoo , Saab Sammy , Klausner Jeffrey D
Data Source:[J].BMC infectious diseases(IF 3.025), 2019, Vol.19 (1), pp.626PubMed
Abstract:BACKGROUND(#br)In the United States Hepatitis C virus (HCV) viral clearance is estimated to range between 20 and 30%. The objective of this study was to estimate the frequency of HCV clearance and identify correlates of viral clearance among patients newly identified as HCV antib...
Author:Suraweera Duminda , Weeratunga Ashley N , Saab Sammy
Data Source:[J].Drug design, development and therapy(IF 3.486), 2016, Vol.10, pp.2119-27PubMed
Abstract:Chronic hepatitis C virus (HCV) infection is a leading cause of health care utilization in the USA. Incidence of cirrhosis from HCV is expected to rise in the near future, further increasing this burden. There is a high medical need for effective, tolerable, safe, all-oral, short...
Author:... Kalwaney Shirley , Saab Sammy , Younossi Zobair
Data Source:[J].BMC gastroenterology(IF 2.11), 2015, Vol.15 (1), pp.175PubMed
Abstract:Non-alcoholic steatohepatitis (NASH) is often seen together with components of metabolic syndrome. The aim of this study was to assess the risk of de novo post-transplant type 2 diabetes (DM) in liver transplant recipients with NASH.;;All adult patients from the Scientific Regist...
Author:Saab Sammy , Medeiros Renata
Data Source:[J].Annals of hepatology(IF 1.671), 2016, Vol.15 (3), pp.377-85PubMed
Abstract:Background and rationale. The post-Liver Transplant Quality of Life (pLTQ) questionnaire, developed in the United States, is a disease-targeted instrument designed to evaluate health-related quality of life (HRQoL) in liver transplant recipients. Our study sought to validate...
Author:... Volk Michael L , Saab Sammy , Sundaram Vinay
Data Source:[J].Annals of hepatology(IF 1.671), 2018, Vol.17 (5), pp.759-768PubMed
Abstract:Alcoholic hepatitis (AH) is a condition of acute liver inflammation in the setting of heavy alcohol use that is often managed with corticosteroids in severe cases. Among non-responders to steroids, however, prognosis is poor with up to 75% mortality within 6 months after treatmen...
Author:Saab Sammy , Medeiros Renata
Data Source:[J].Annals of hepatology(IF 1.671), 2016, Vol.15 (3), pp.377-385PubMed
Abstract:BACKGROUND AND RATIONALE(#br)The post-Liver Transplant Quality of Life (pLTQ) questionnaire, developed in the United States, is a disease-targeted instrument designed to evaluate health-related quality of life (HRQoL) in liver transplant recipients. Our study sought to valid...
Author:Jacobs R Jake , Meyerhoff Allen S , Saab Sammy
Data Source:[J].Digestive diseases and sciences(IF 2.26), 2005, Vol.50 (8), pp.1525-31PubMed
Abstract:Chronic liver disease patients may benefit from certain vaccines, but their immunization coverage levels have not been widely studied. We examined the serologic and vaccination status of 693 chronic liver disease patients from 37 primary care and specialist centers. Patients in p...
Author:... McWilliams Justin P , Wang Hanlin L , Saab Sammy
Data Source:[J].Hepatology research : the official journal of the Japan Society of Hepatology(IF 2.072), 2013PubMed
Abstract:The incidence of hepatocellular carcinoma (HCC) appears to be increasing across the globe. Well-established protocols for screening are available, and the most common underlying liver problem associated with the development of HCC is cirrhosis. However, with few exceptions, patie...
Author:Saab Sammy , McWilliams Justin P ...
Data Source:[J].Clinical and translational gastroenterology, 2019, Vol.10 (7), pp.e00063PubMed
Abstract:OBJECTIVES(#br)To investigate the safety profile and diagnostic efficacy of transjugular liver biopsy (TJLB), with a focus on patients with severe coagulopathies and with multiple biopsies.(#br)METHODS(#br)Clinical, laboratory, and demographic information was collected on 1,...

Being retrieved, please wait for a moment...

International Cooperation:cnki.scholar@cnki.net, +86-10-82896619   Feedback:scholar@cnki.net

×